SEC FILLINGS DISCLOSED/ Sep 5, $Dyne Therapeutics (DYN.US)$ Officer McNeill Jonathan intends to sell 166.77K shares of its common stock on Sep 5, with a total market value of approximately $5.61 million.
McNeill Jonathan has reduced shareholding in $Dyne Therapeutics (DYN.US)$ by 4,528 shares since Jun 11, 2024, with a total value of approximately $179.16K.
What is Form 144?
Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.
